California State Teachers Retirement System (CalSTRS)’s Aevi Genomic Medicine Inc GNMX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio GNMX Stock Details GNMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-55,192	Closed	-$103K	–	3097
2017 Q1	$103K	Sell	55,192 -800	-1%	-$3.62K	﹤0.01%	2925
2016 Q4	$290K	Sell	55,992 -1,600	-3%	-$8.42K	﹤0.01%	2776
2016 Q3	$321K	Buy	57,592 +6,500	+13%	+$37.1K	﹤0.01%	2712
2016 Q2	$284K	Buy	51,092 +3,746	+8%	+$19.7K	﹤0.01%	2788
2016 Q1	$208K	Buy	47,346 +6,246	+15%	+$25.7K	﹤0.01%	2791
2015 Q4	$247K	Buy	41,100 +10,466	+34%	+$71.1K	﹤0.01%	2795
2015 Q3	$240K	Sell	30,634 -100	-0.3%	-$775	﹤0.01%	2824
2015 Q2	$188K	Buy	+30,734	New	+$238K	﹤0.01%	2944

Other funds holding GNMX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s GNMX Position: Q2 2017 in Review

California State Teachers Retirement System (CalSTRS) sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2017, closing a stake of 55,192 shares — an estimated $103K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in GNMX in Q2 2015 and held it in 8 quarters. The position peaked at $321K in Q3 2016. 51 funds tracked by Wall St. Rank hold GNMX as of Q2 2017.

California State Teachers Retirement System (CalSTRS) reported no remaining Aevi Genomic Medicine Inc position as of Q2 2017 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 55,192 Aevi Genomic Medicine Inc shares in Q2 2017, an estimated $103K.
California State Teachers Retirement System (CalSTRS) first reported a position in Aevi Genomic Medicine Inc in Q2 2015 and held it in 8 quarters.
California State Teachers Retirement System (CalSTRS)'s Aevi Genomic Medicine Inc position peaked at $321K in Q3 2016.
51 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2017.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2017, filed 15 Aug 2017.